ZA967800B - Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them - Google Patents

Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them

Info

Publication number
ZA967800B
ZA967800B ZA967800A ZA967800A ZA967800B ZA 967800 B ZA967800 B ZA 967800B ZA 967800 A ZA967800 A ZA 967800A ZA 967800 A ZA967800 A ZA 967800A ZA 967800 B ZA967800 B ZA 967800B
Authority
ZA
South Africa
Prior art keywords
heteroaryllsubstituted
pharmaceutical compositions
acryloylguanidine
derivatives
acryloylguanidine derivatives
Prior art date
Application number
ZA967800A
Other languages
English (en)
Inventor
Kazumi Kikuchi
Akira Toyoshima
Toshio Okazaki
Massahiro Takanashi
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of ZA967800B publication Critical patent/ZA967800B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA967800A 1995-09-20 1996-09-16 Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them ZA967800B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24171695 1995-09-20

Publications (1)

Publication Number Publication Date
ZA967800B true ZA967800B (en) 1997-04-03

Family

ID=17078479

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA967800A ZA967800B (en) 1995-09-20 1996-09-16 Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them

Country Status (13)

Country Link
EP (1) EP0861831A4 (ko)
KR (1) KR19990063589A (ko)
CN (1) CN1196721A (ko)
AU (1) AU702092B2 (ko)
BR (1) BR9610530A (ko)
CA (1) CA2232497A1 (ko)
CZ (1) CZ84098A3 (ko)
HU (1) HUP9901336A3 (ko)
NO (1) NO981241L (ko)
PL (1) PL326033A1 (ko)
SK (1) SK35198A3 (ko)
WO (1) WO1997011055A1 (ko)
ZA (1) ZA967800B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002515854A (ja) * 1995-08-02 2002-05-28 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体拮抗薬
US6258829B1 (en) * 1997-03-06 2001-07-10 Toa Eiyo Ltd. Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
JP2003507468A (ja) * 1999-08-23 2003-02-25 スミスクライン・ビーチャム・コーポレイション 脂肪酸シンターゼ阻害剤
EP1695716A2 (en) * 2000-12-26 2006-08-30 Sankyo Company, Limited Medicinal compositions containing diuretics and insulin sensitizers
AU2005264917A1 (en) 2004-06-16 2006-01-26 Wyeth Diphenylimidazopyrimidine and -imidazole amines as inhibitors of B-secretase
CN1968945A (zh) 2004-06-16 2007-05-23 惠氏公司 用于抑制β分泌酶的氨基-5,5-二苯基咪唑酮衍生物
BRPI0606690A2 (pt) 2005-01-14 2009-07-14 Wyeth Corp composto; uso do composto para o tratamento de uma doença ou distúrbio associado com uma atividade excessiva de bace; e composição farmacêutica
BRPI0607094A2 (pt) 2005-02-01 2009-08-04 Wyeth Corp composto da fórmula i; uso do composto para o tratamento de uma doença ou distúrbio associado à atividade excessiva de bace em um paciente que dele necessita; uso do composto para modular a atividade de bace; e composição farmacêutica
KR20070102751A (ko) 2005-02-14 2007-10-19 와이어쓰 β-세크레타제 억제제로서의 아졸릴아실구아니딘
WO2006088694A1 (en) 2005-02-14 2006-08-24 Wyeth SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
AU2006266167A1 (en) 2005-06-30 2007-01-11 Wyeth Amino-5-(6-membered)heteroarylimidazolone compounds and the use thereof for beta-secretase modulation
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
CA2623245A1 (en) 2005-09-26 2007-04-05 Wyeth Amino-5- [4- (difluoromethoxy) phenyl] -5-phenylimidazolone compounds as inhibitors of the beta-secretase (bace)
WO2007100536A1 (en) 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
AR065814A1 (es) 2007-03-23 2009-07-01 Wyeth Corp Derivados de 5-fenilimidazolona,inhibidores de beta-secretasa,composiciones farmaceuticas que los contienen y usos para prevenir y/o tratar trastornos asociados a niveles beta-amiloides elevados.
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
JP3162572B2 (ja) * 1993-04-28 2001-05-08 住友製薬株式会社 インドロイルグアニジン誘導体
US5401758A (en) * 1993-10-07 1995-03-28 Bristol-Myers Squibb Company Pyridinyl cyanoguanidine compounds
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
JPH0959245A (ja) * 1995-08-25 1997-03-04 Yamanouchi Pharmaceut Co Ltd N−(2−プロペノイル)グアニジン誘導体

Also Published As

Publication number Publication date
EP0861831A1 (en) 1998-09-02
PL326033A1 (en) 1998-08-17
MX9802238A (es) 1998-08-30
WO1997011055A1 (fr) 1997-03-27
AU702092B2 (en) 1999-02-11
EP0861831A4 (en) 1998-11-11
NO981241D0 (no) 1998-03-19
CZ84098A3 (cs) 1998-09-16
AU7000796A (en) 1997-04-09
HUP9901336A2 (hu) 1999-08-30
SK35198A3 (en) 1999-06-11
KR19990063589A (ko) 1999-07-26
CA2232497A1 (en) 1997-03-27
HUP9901336A3 (en) 2000-02-28
BR9610530A (pt) 1999-07-06
NO981241L (no) 1998-05-20
CN1196721A (zh) 1998-10-21

Similar Documents

Publication Publication Date Title
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
IL119078A (en) Substituted benzylaminopiperidine compounds and pharmaceutical compositions comprising them
IL122485A0 (en) Arylsulfonylaminobenzene derivatives and pharmaceutical compositions containg the same
IL116917A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
HUP9900424A2 (hu) Tiazolil-benzfurán-származékok és a vegyületeket tartalmazó gyógyászati készítmények
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
IL125710A0 (en) Arylglycinamide derivatives their preparation and pharmaceutical compositions containing them
HUP9901344A3 (en) Radicicol derivatives and pharmaceutical compositions thereof
IL115905A0 (en) Sordarin derivatives their preparation and pharmaceutical compositions containing them
HUP9802290A3 (en) Pyrrole derivatives and pharmaceutical compositions containing them
IL117554A0 (en) Imidazoquinazolines their preparation and pharmaceutical compositions containing them
AU5856898A (en) Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them
ZA967800B (en) Heteroaryllsubstituted acryloylguanidine derivatives and pharmaceutical compositions comprising them
HUP9602196A2 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
HUP0100085A3 (en) Biphenylamidine derivatives and pharmaceutical compositions containing them
HUP0002331A3 (en) 20-aralkyl-5alpha-pregnane derivatives and pharmaceutical compositions thereof
IL118427A (en) N-acyl-2 aryl cycloalkylmethylamine derivatives as melatonergics and pharmaceutical compositions comprising them
IL117397A (en) Substituted naphthyl compounds and pharmaceutical compositions comprising them
IL115113A0 (en) Pyridinium derivatives and pharmaceutical compositions containing them
IL119371A0 (en) Sulfonylaminopyrimidines their preparation and pharmaceutical compositions containing them
IL118672A (en) Benzisothiazolyl-substituted aminomethylchromans their preparation and pharmaceutical compositions containing them
HU9500386D0 (en) Benzodiazepine derivatives and pharmaceutical compositions containing them
IL120722A0 (en) Carbohydrate derivatives and pharmaceutical compositions containing them
GB9501286D0 (en) Pharmaceutical compositions and preparations thereof
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them